BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2316675)

  • 1. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
    Morris DJ; Souness GW
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other physiological considerations of protective mechanisms of mineralocorticoid action.
    Souness GW; Myles K; Morris DJ
    Steroids; 1994 Feb; 59(2):142-7. PubMed ID: 8191544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.
    Stewart PM; Wallace AM; Atherden SM; Shearing CH; Edwards CR
    Clin Sci (Lond); 1990 Jan; 78(1):49-54. PubMed ID: 2153495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11 beta-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone.
    Náray-Fejes-Tóth A; Watlington CO; Fejes-Tóth G
    Endocrinology; 1991 Jul; 129(1):17-21. PubMed ID: 2055180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR; Stewart PM
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
    Bonvalet JP; Doignon I; Blot-Chabaud M; Pradelles P; Farman N
    J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat.
    Souness GW; Morris DJ
    Endocrinology; 1989 Mar; 124(3):1588-90. PubMed ID: 2917528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid metabolism determines mineralocorticoid specificity in the toad bladder.
    Gaeggeler HP; Edwards CR; Rossier BC
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F690-5. PubMed ID: 2508490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme- and mineralocorticoid receptor-controlled electrogenic Na+ absorption in human rectum in vitro.
    Epple HJ; Schulzke JD; Schmitz H; Fromm M
    Am J Physiol; 1995 Jul; 269(1 Pt 1):G42-8. PubMed ID: 7631800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rat intestine.
    Pácha J; Miksík I
    Life Sci; 1994; 54(11):745-9. PubMed ID: 8107525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbenoxolone administered acutely to adrenalectomized rats (in vivo) on renal and hepatic handling of corticosterone by 11 beta-hydroxysteroid dehydrogenase.
    Latif SA; Semafuko WE; Morris DJ
    Steroids; 1992 Oct; 57(10):494-501. PubMed ID: 1455457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder.
    Brem AS; Matheson KL; Conca T; Morris DJ
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F700-4. PubMed ID: 2508491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of mineralocorticoid action of carbenoxolone.
    Armanini D; Karbowiak I; Krozowski Z; Funder JW; Adam WR
    Endocrinology; 1982 Nov; 111(5):1683-6. PubMed ID: 6290195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [11 beta-hydroxysteroid dehydrogenase and steroid receptors].
    Takeda R; Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):658-64. PubMed ID: 1516720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
    Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the renal type III corticosteroid-binding site the collecting duct-specific isoform of 11 beta-hydroxysteroid dehydrogenase?
    Náray-Fejes-Tóth A; Rusvai E; Fejes-Tóth G
    Endocrinology; 1994 Apr; 134(4):1671-5. PubMed ID: 8137730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of adrenocorticosteroids on 11 beta-hydroxysteroid dehydrogenase bioactivity at the anterior pituitary and hypothalamus in rats.
    Idrus RB; Mohamad NB; Morat PB; Saim A; Abdul Kadir KB
    Steroids; 1996 Aug; 61(8):448-52. PubMed ID: 8870163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital and acquired syndromes of apparent mineralocorticoid excess.
    Edwards CR; Walker BR; Benediktsson R; Seckl JR
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
    Funder JW; Pearce PT; Myles K; Roy LP
    FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
    Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
    Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.